On 12/9/24, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock enjoyed a major increase of 16.0%, closing at $3.98. Moreover, this advance was accompanied by unusually high trading volume at 181% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 13.1% during the last week.
Current PriceTarget Research Rating
Ironwood Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment